MedTrace Logo

Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss

NCT07073521 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-07-30

No results posted yet for this study

Summary

The goal of this study is to develop and pilot test a therapeutic strategy combining cognitive behavioral therapy (CBT) with mindfulness practices tailored for individuals adjusting to vision loss. The study will begin with focus groups to inform the design of the intervention. Participants will complete brief surveys on their background and experiences with vision loss prior to attending a focus group, and some may be invited to a second session to provide additional feedback before preliminary testing begins. In the pilot phase, participants will attend weekly group therapy sessions using the developed intervention and complete assessments before and after the program, including questions about vision status, demographics, and experiences with vision loss.

Conditions

  • Depression, Anxiety
  • Visual Impairment
  • Adjustment
  • Adjustment Disorder With Anxious Mood
  • Adjustment Disorder With Depressed Mood
  • Blindness, Acquired
  • Blindness and Low Vision
  • Vision Loss

Interventions

BEHAVIORAL

Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss

The intervention will be an 8-week integrated group therapy curriculum combining cognitive behavioral therapy (CBT) with mindfulness practices designed for individuals adjusting to vision loss.

Sponsors & Collaborators

  • The Chicago Lighthouse

    lead OTHER

Principal Investigators

  • Chief Research Officer · The Chicago Lighthouse

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2027-07-31
Completion
2027-07-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07073521 on ClinicalTrials.gov